Statins for age-related macular degeneration

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Gehlbach, Peter ^a   Li, Tianjing ^b   Hatef, Elham ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SIMVASTATIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; FOLLOW UP; HUMAN; LENS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

EID: 70049116259     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006927.pub2     Document Type: Review

References (43)

1. * Martini E, Scorolli L, Burgagni MS, Fessehaie S. [Valutazione degli effetti retinici della somministrazione di simvastatina in pazienti affetti da degenerazione maculare senile]. Annali Di Ottalmologia e Clinica Oculistica 1991;117(11):1121-1126
2. Della Valle V, Scorolli L, Meduri R. Retinal effects of Simvastatin in patients affected by age related macular degeneration [Effetti retinici della Simvastatina in pazienti affetfi da degenerazione maculare senile correlata all'eta]. Annali Di Ottalmologia e Clinica Oculistica 2000;126(5-6):89-95.
3. Della Valle V, Scorolli L, Meduri R. Retinal effects of Simvastatin in SMD: Cases up-date [Effetti retinici della Simvastatina nella DMS: Aggiornamento casistica]. Annali Di Ottalmologia e Clinica Oculistica 2000;126(11-12):249-255
4. Sen K, Misra A, Kumar A, Pandey RM. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Research & Clinical Practice 2002;56(1):1-11. (Pubitemid 34170743)
5. * Drobek-Slowik M, Karczewicz D, Safranow K, Jakubowska K, Chlubek D. Use of statins as a form of protection against age-related macular degeneration (AMD) [Leczenie statynami jako forma ochrony przed zwyrodnieniem plamki zwiazanym z wiekiem (AMD)]. Klinika Oczna 2008;1-3:50-54
6. * Guymer RH, Dimitrov PN, Varsamidis M, Lim LL, Baird PN, Vingrys AJ, et al.Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The agerelated maculopathy statin study (ARMSS). Clinical Interventions in Aging 2008;3(3):581-593
7. Guymer RH, Robman L, Varsamidis M, Dimitrov P, Hunt N, Lim L, et al.Can HMG Co-A Reductase Inhibitors ("Statins") Slow the Progression of AMD?. Investigative Ophthalmology & Visual Sciences. 2005; Vol.46:ARVO E-abstract 2364.
8. American Academy of Ophthalmology Retina Panel. Age-Related Macular Degeneration Limited Revision Preferred Practice Pattern. American Academy of Ophthalmology 2006.
9. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology 2001;119(10):1417-1436
10. Complications of Age-Related Macular Degeneration Prevention Trial Study Group. The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology. Clinical Trials 2004;1(1):91-107.
11. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003;290(15):2057-2060 (Pubitemid 37430590)
12. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses . In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
13. Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, Ares MPS, et al.HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003;23(1):58-63. (Pubitemid 36091626)
14. Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2006, Issue 2. [Art. No.: CD000254. DOI: 10.1002/14651858.CD000254. pub2]
15. Evans JR, Henshaw KS. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database of Systematic Reviews 2008, Issue 1. [Art. No.: CD000253. DOI: 10.1002/14651858.CD000253.pub2]
16. Friedman E. Update of the vascular model of AMD. British Journal of Ophthalmology 2004;88(2):161-163
17. Geltzer A, Turalba A, Vedula SS. Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 4. [Art. No.: CD005022. DOI: 10.1002/14651858.CD005022.pub2] (Pubitemid 351805383)
18. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-136
19. Gurne DH, Tso MO, Edward DP, Ripp H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 1991;98(5):602-607
20. Guymer RH, Chiu AW, Lim L, Baird PN. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?. Survey of Ophthalmology 2005;50(2):194-206. (Pubitemid 40340950)
21. Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN. Risk of macular degeneration in users of statins: cross sectional study. BMJ 2001;323(7309):375-376 (Pubitemid 32762463)
22. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
23. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99(6):933-943
24. Klein R, Klein BE, Jensen SC, Cruickshanks KJ, Lee KE, Danforth LG, et al.Medication use and the 5-year incidence of early age-related maculopathy: The Beaver Dam Eye Study. Archives of Ophthalmology 2001;119(9):1354-1359 (Pubitemid 32994881)
25. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 2002;109(10):1767-1779 (Pubitemid 35222560)
26. Klein R, Deng Y, Klein BE, Hyman L, Seddon J, Frank RN, et al.Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Ophthalmology 2007;143(3):473-483 (Pubitemid 46273353)
27. Klein R, Knudtson MD, Klein BE. Statin use and the five-year incidence and progression of age-related macular degeneration. American Journal of Ophthalmology 2007;144(1):1-6. (Pubitemid 46161820)
28. McGwin G Jr, Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. British Journal of Ophthalmology 2003;87(9):1121-1125 (Pubitemid 37064888)
29. McGwin G, Modjarrad K, Hall TA, Xie A, Owsley C. 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Archives of Ophthalmology 2006;124(1):33-37 (Pubitemid 43063886)
30. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102(10):1450-1460 (Pubitemid 26357144)
31. Anonymous. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Archives of Ophthalmology 1991;109(8):1109-1114
32. Anonymous. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Archives of Ophthalmology 1994;112(4):500-509
33. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Progress in Retinal & Eye Research 2001;20(3):385-414.
34. Sagara N, Kawaji T, Takano A, Inomata Y, Inatani M, Fukushima M, et al.Effect of pitavastatin on experimental choroidal neovascularization in rats. Experimental Eye Research 2007;84(6):1074-1080 (Pubitemid 46770720)
35. Smeeth L, Cook C, Chakravarthy U, Hubbard R, Fletcher AE. A case control study of age related macular degeneration and use of statins. British Journal of Ophthalmology 2005;89(9):1171-1175 (Pubitemid 41224469)
36. Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. British Journal of Clinical Pharmacology 2009;67(1):99-109.
37. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al.Risk factors for age-related macular degeneration, Pooled findings from three continents. Ophthalmology 2001;108(4):697-704. (Pubitemid 32238465)
38. Spaide RF, Ho-Spaide WC, Browne RW, Armstrong D. Characterization of peroxidized lipids in Bruch's membrane. Retina 1999;19(2):141-147 (Pubitemid 30368160)
39. Tan JS, Mitchell P, Rochtchina E, Wang JJ. Statins and the long-term risk of incident age-related macular degeneration: The Blue Mountains Eye Study. American Journal of Ophthalmology 2007;143(4):685-687 (Pubitemid 46452504)
40. van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ 2003;326(7383):255-256 (Pubitemid 36169589)
41. Vedula SS, Krzystolik MG. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2008, Issue 2. [Art. No.: CD005139. DOI: 10.1002/14651858.CD005139.pub2]
42. Virgili G, Bini A. Laser photocoagulation for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 3. [Art. No.: CD004763. DOI: 10.1002/14651858.CD004763.pub2] (Pubitemid 351805545)
43. Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-relatedmacular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 3. [Art. No.: CD002030. DOI: 10.1002/14651858.CD002030.pub3] (Pubitemid 351805609)